We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+10.8%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$87.5B
AUM Growth
+$6.24B
Cap. Flow
-$2.46B
Cap. Flow %
-2.82%
Top 10 Hldgs %
10.13%
Holding
4,337
New
572
Increased
1,477
Reduced
1,498
Closed
412

Top Buys

Rank Stock Value
1
EMR icon
Emerson Electric
EMR
+$546M
2
AMZN icon
Amazon
AMZN
+$515M
3
TSLA icon
Tesla
TSLA
+$389M
4
NFLX icon
Netflix
NFLX
+$322M
5
ADBE icon
Adobe
ADBE
+$305M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$836M
2
CELG
Celgene Corp
CELG
+$460M
3
NVDA icon
NVIDIA
NVDA
+$429M
4
COP icon
ConocoPhillips
COP
+$311M
5
BIIB icon
Biogen
BIIB
+$301M

Sector Composition

Rank Sector Weight
1 Technology 15.8%
2 Consumer Discretionary 11.76%
3 Healthcare 10.16%
4 Financials 7.89%
5 Industrials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVTA
4176
DELISTED
Invitae Corporation
NVTA
-12,275
Closed -$237K
NETI
4177
DELISTED
Eneti Inc.
NETI
-3,003
Closed -$170K
SGEN
4178
DELISTED
Seagen Inc. Common Stock
SGEN
-177,656
Closed -$18.8M
AVID
4179
DELISTED
Avid Technology Inc
AVID
-10,639
Closed -$66K
RETA
4180
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-4,300
Closed -$784K
CS
4181
DELISTED
Credit Suisse Group
CS
-40,388
Closed -$493K
CIH
4182
DELISTED
China Index Holdings Limited American Depository Shares
CIH
-112,027
Closed -$436K
AGFS
4183
DELISTED
AgroFresh Solutions Inc
AGFS
-81,057
Closed -$213K
MYOV
4184
DELISTED
Myovant Sciences Ltd.
MYOV
-18,785
Closed -$98K
LHCG
4185
CALL
DELISTED
LHC Group LLC
LHCG
-22,000
Closed -$2.5M
AVYA
4186
PUT
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
-52,000
Closed -$532K
AGTC
4187
DELISTED
Applied Genetic Technologies Corporation
AGTC
-54,702
Closed -$228K
SECO
4188
DELISTED
Secoo Holding Limited ADR
SECO
-1,443
Closed -$97K
ZEN
4189
PUT
DELISTED
ZENDESK INC
ZEN
-24,900
Closed -$1.81M
FNHC
4190
DELISTED
FedNat Holding Company Common Stock
FNHC
-18,686
Closed -$261K
MTOR
4191
DELISTED
MERITOR, Inc.
MTOR
-74,381
Closed -$1.38M
SAFM
4192
CALL
DELISTED
Sanderson Farms Inc
SAFM
-15,700
Closed -$2.38M
SAFM
4193
PUT
DELISTED
Sanderson Farms Inc
SAFM
-1,900
Closed -$288K
COHR
4194
CALL
DELISTED
Coherent Inc
COHR
-20,800
Closed -$3.2M
COHR
4195
PUT
DELISTED
Coherent Inc
COHR
-36,700
Closed -$5.64M
CERN
4196
CALL
DELISTED
Cerner Corp
CERN
-65,100
Closed -$4.44M
CERN
4197
PUT
DELISTED
Cerner Corp
CERN
-20,000
Closed -$1.36M
ANAT
4198
PUT
DELISTED
American National Group, Inc. Common Stock
ANAT
-10,000
Closed -$1.24M
VNE
4199
CALL
DELISTED
Veoneer, Inc.
VNE
-68,700
Closed -$1.03M
RRD
4200
DELISTED
RR Donnelley & Sons Co.
RRD
-229,260
Closed -$864K

Similar funds

David Shaw's Q4 2019 Portfolio in Review

As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
  • David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
  • David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
  • David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
  • David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
  • David Shaw opened 572 new positions and closed 412 in Q4 2019.
  • David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.

Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.